Award
NIH Reporter #11237560
Pharmacogenetics of the Response to a GLP1R Agonist
Recipient
University of Maryland Baltimore
Award Amount
$672,063.00
Ceiling
$672,063.00
Awarded
December 04, 2025
Identifier
11237560
NIH/NIDDK awarded approximately $672,063 for a pharmacogenetics study on GLP1R agonist response in type 2 diabetes, aiming to develop personalized treatment biomarkers.
Description
The project involves a genome-wide association study to identify genetic variants predicting responses to GLP1R agonists in type 2 diabetic patients, focusing on the Old Order Amish population. The study aims to develop predictive pharmacogenomic biomarkers to enable personalized treatment approaches for diabetes. Funded by NIH/NIDDK as part of the TOPMed program, the project duration is from December 2021 to November 2026, with collaboration from the University of Maryland Baltimore.